After the patients were grouped according to gender, smoking status, obesity classification, and the presence of comorbid diseases such as DM, HT, HL, and metabolic syndrome, they were compared in terms of serum ATF4 and TLR4 levels, but no difference was observed between the groups. The gene discussed is TLR4; the disease is hematocrit.